POPULATION-BASED INCIDENCE OF MYOPERICARDITIS AFTER COVID-19 VACCINATION IN DANISH ADOLESCENTS

In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.

Automated summary

A nationwide study in Denmark found that the incidence of myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was higher among males aged 12-17 years compared to reports from the United States.